May 15 (Reuters) - At least 20 people in Japan who took
Amgen's ( AMGN ) rare disease drug have died, while 22 others
developed potentially fatal liver injuries, the Wall Street
Journal reported on Friday, citing partner Kissei
Pharmaceutical.